Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05821244 · ClinicalTrials.gov registry record · NA
Exercise Timing in Breast Cancer Patients
A NA study, sponsored by University of Utah.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT05821244 is a NA study that has completed, run by University of Utah. The registered enrollment target is 32 participants.
The verdict
NCT05821244, a NA study, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
The purpose of this study is to demonstrate the feasibility of assigning breast cancer survivors currently receiving chemotherapy to exercise at a specific time of day, e.g., morning or afternoon/evening, for a 4-week exercise intervention. Information gathered from this study will help inform a future, larger trial. Study Aims: 1\. Assess the feasibility of engaging in exercise at an assigned time-of-day (e.g., morning or afternoon/evening) in breast cancer survivors on chemotherapy. Hypothesis: Assigning windows of time within the day to complete exercise (e.g. 5-10am exercise start time vs. 3-8pm exercise start time) will be feasible among this patient population. 1a. Determine the acceptability engaging in exercise at an assigned time-of-day (e.g., morning or afternoon/evening) in breast cancer survivors on chemotherapy. Hypothesis: Engaging in exercise at an assigned time-of-day will be acceptable in this patient population. 2\. To generate evidence on the magnitude of the effect sizes and outcome variability of physical function and human performance variables. Tests to be conducted at baseline and end of study to measure physical function and human performance variables include: Timed up and go test, 30-second chair stand, handgrip strength, cardiorespiratory fitness.
Interventions
- BEHAVIORAL Exercise Timing Groups
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2023-07-05 |
| Est. Completion | 2024-08-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05821244
The ClinicalTrials.gov registry entry for NCT05821244 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Exercise Timing Groups is the first listed.
NCT05821244 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05821244 about?
NCT05821244 is a clinical study titled "Exercise Timing in Breast Cancer Patients". The purpose of this study is to demonstrate the feasibility of assigning breast cancer survivors currently receiving chemotherapy to exercise at a specific time of day, e.g., morning or afternoon/evening, for a 4-week exercise intervention. Information gathered from this study will help inform a fut...
What is the current status of trial NCT05821244?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2023-07-05. Estimated completion is 2024-08-05.
What interventions are being tested in trial NCT05821244?
The interventions under investigation include: Exercise Timing Groups (BEHAVIORAL).
Who is sponsoring clinical trial NCT05821244?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.